Skip to main content
Clinical Trials/KCT0004266
KCT0004266
Not yet recruiting
未知

A Clinical Pilot Study to Evaluate the Efficacy of Oral Intake of Phellinus linteus(sanghuang) Extract on Knee joint and Articular Cartilage: Randomized, Double-blind Controlled Trial

Cheonan Korean Medicine Hospital of Daejeon University0 sites24 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the musculo-skeletal system and connective tissue
Sponsor
Cheonan Korean Medicine Hospital of Daejeon University
Enrollment
24
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Cheonan Korean Medicine Hospital of Daejeon University

Eligibility Criteria

Inclusion Criteria

  • (1\) 40\-75 year old male and female with knee pain for 6 months or more
  • (2\) A Kellgren\-Lawrence grading scale of 1 grade or 2 grade on both knee X\-ray examinations
  • (3\) If subject is taking arthritic medications, subject has not changed his/her medication within the past a month
  • (4\) Subject who agrees to participate in the study and signs the informed consent form

Exclusion Criteria

  • (1\) A patient who are currently being treated for clinically significant acute or chronic cardiocerebrovascular system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, nervous system, musculoskeletal disorders, mental, infectious and blood and tumor diseases
  • (2\) A person who is arthritis due to a specific factor other than degenerative
  • (3\) Those who have a history of fractures of the lower limb within the last 3 months
  • (4\) Those who have creatinine blood level that is more than twice the normal upper limit of the organ
  • (5\) A patient who received intra\-articular injection with hyaluronic acid or steroids within 3 months of the study
  • (6\) Those who have AST or ALT blood level that is 3 times higher than normal upper limit
  • (7\) Those who have uncontrolled hypertension(160/100mmHg ??)
  • (8\) Patients taking medication for psychiatric disorders
  • (9\) Those who have been taking herbal medicine for the last two weeks
  • (10\) Those who have received other research drugs within the last 4 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials